Yes, Blood Malignancies Can Cause Arthritis
Blood malignancies, particularly leukemias and lymphomas, can directly cause arthritis and should be considered in the differential diagnosis of any patient presenting with new-onset joint symptoms, especially when accompanied by systemic features or atypical presentations.
Key Clinical Presentations
Leukemic arthritis occurs in approximately 20% of leukemia patients and 2% of lymphoma patients at initial presentation 1. The arthritis can appear before, simultaneously with, or after the diagnosis of malignancy 2.
Most Common Pattern
- Acute symmetrical polyarthritis mimicking rheumatoid arthritis is the most frequent presentation 2
- Most commonly affected joints: knee, wrist, and ankle 2
- Both acute and chronic leukemias can cause arthritis 2
Critical Red Flags to Recognize
When evaluating a patient with apparent inflammatory arthritis, these features should immediately raise suspicion for underlying hematologic malignancy:
Pain-Inflammation Mismatch
Severe pain that is disproportionate to the degree of physical swelling or inflammation is a crucial diagnostic clue 2, 1, 3. This is one of the most important distinguishing features from primary rheumatic disease.
Laboratory Abnormalities
- Anemia (present in 81% of cases) 1
- Thrombocytopenia (present in 78% of cases) 1
- Elevated LDH (3-4 times normal) 1
- Notably, 50% of patients have normal leukocyte counts, so a normal white blood cell count does not exclude malignancy 1
Clinical Features
- Constitutional symptoms: fever, fatigue, weight loss, night sweats 3
- Hip involvement is particularly common in leukemic arthritis 1
- Synovial fluid blast cells identified in 33% of cases when aspirated 2
Diagnostic Pitfalls to Avoid
The Steroid Response Trap
A good response to corticosteroids is a major diagnostic pitfall 4, 3. Hematologic malignancies presenting as rheumatic syndromes often respond well to steroids, which can mislead clinicians into believing they are treating a primary rheumatic disease. This is particularly dangerous because:
- Pre-treatment with steroids can mask the malignancy and delay diagnosis 1
- Steroid exposure before chemotherapy may lead to steroid-resistant malignancy that is more difficult to treat 1
Imaging Limitations
Imaging is often unrevealing early in the disease:
- Plain radiographs were abnormal in only 6% of cases (1/16) 1
- Joint ultrasound was abnormal in 60% of cases (3/5) 1
Differential Diagnosis Framework
When evaluating arthritis in a patient with known or suspected malignancy, consider three distinct entities 5:
- Direct leukemic/lymphomatous arthritis - malignant cells infiltrating synovium
- Metastatic disease - bone metastases causing joint symptoms
- Paraneoplastic syndromes - immune-mediated arthritis triggered by malignancy
Advanced imaging (CT, MRI, bone scintigraphy, or PET-CT) may be necessary to distinguish these entities 5.
Specific Malignancies and Arthritis Patterns
Multiple hematologic malignancies can present with arthritis 4, 3:
- Multiple myeloma with amyloidosis causing polyarthritis
- Angioimmunoblastic T-cell lymphoma (AITL) presenting as polyarthritis
- Acute myeloid leukemia causing migratory arthritis
- Anaplastic large T-cell lymphoma mimicking giant cell arteritis
- Marginal zone lymphoma with rheumatologic features
- Myelodysplastic syndrome (MDS) with inflammatory arthritis
Recommended Diagnostic Approach
Before initiating any immunosuppressive therapy or steroids for presumed inflammatory arthritis, obtain:
- Complete blood count with differential - looking specifically for cytopenias (even with normal WBC)
- LDH level - elevation is highly suggestive
- Peripheral blood smear review - may reveal abnormal cells
- Bone marrow biopsy if any red flags are present 3
The hip is a particularly important joint to examine, as it is frequently affected in leukemic arthritis 1. In children presenting with musculoskeletal symptoms, diagnosing leukemia early is critical because steroid use before diagnosis can lead to treatment-resistant disease 1.
Treatment Response as Diagnostic Tool
Leukemic arthritis responds well to chemotherapy directed at the underlying malignancy, not to rheumatic disease treatments 2. If a patient's arthritis does not improve with standard rheumatologic therapy, or if improvement is only seen with high-dose steroids, reconsider the diagnosis and pursue hematologic evaluation.